However, during the study, our research group found that in pancreatic adenocarcinoma, the group with high NPLOC4 expression had longer survival times (Supplementary Fig. 3), suggesting that the effect of NPLOC4 is specific to the tumor type. This evidence concerns the gene NPLOC4 and pancreatic adenocarcinoma.